Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose vs Normal Dose Ketorolac for Postoperative Pain
NCT05206110Completed
- Sponsor
- Jessa Hospital
- Start
- Apr 2022
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ketorolac in postoperative pain (2 arms), sponsored by Jessa Hospital. Primary endpoint: Pain at rest 8 hours after surgery. Started Apr 2022; status: completed.
02
Drugs
ketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05206110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05206110.